Prem S Shah insider trades: CVS HEALTH (CVS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Prem reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | CVS | ↑ Buy | 23,855 | $83.89 | $2.0M | Direct | Nov 6, 2026 (0d) |
| Feb 16, 2024 | CVS | ↓ Sell | 29,473 | $76.95 | $2.3M | Direct | Feb 16, 2024 (0d) |
| Apr 8, 2022 | CVS | ↓ Sell | 16,954 | $105.00 | $1.8M | Direct | Apr 12, 2022 (4d) |
| Mar 30, 2022 | CVS | ↓ Sell | 5,346 | $104.70 | $560K | Direct | Mar 31, 2022 (1d) |
| Mar 17, 2022 | CVS | ↓ Sell | 4,624 | $106.65 | $493K | Direct | Mar 18, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CVS insiders
Open-market trades in the last 12 months
About Prem S Shah's insider trades
Prem S Shah is EVP and Group President at CVS HEALTH (CVS). Since Mar 17, 2022, Prem has reported 1 open-market purchase worth $2.0M and 4 sales worth $5.1M on SEC Form 4. In the last 12 months: 1 buy ($2.0M).
Their filings also include shares withheld for taxes (11 filings), grants and awards (10 filings), option exercises (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CVS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.